Tag: GPT4

Browse our exclusive articles!

OpenAI CEO Sam Altman discusses demand for GPT-4: Growing desire for AI’s advanced capabilities

Get the latest insights from OpenAI CEO Sam Altman as he addresses the buzz around GPT-4, debunking hype and discussing AI biases. Don't be misled by wild predictions!

Is ChatGPT Declining in Quality?

Concerns about ChatGPT's declining performance and the impact of GPT-4 versus GPT-3.5 are examined in this article. Findings suggest changes in accuracy and responsiveness, raising questions about OpenAI's direction.

The puzzling decline: The enigma of ChatGPT’s declining intelligence

Discover the concerning decline in performance of OpenAI's ChatGPT AI model, GPT-4, with significant variations noted by Stanford and Berkeley researchers.

Meta executive Nick Clegg criticizes AI as quite stupid while company announces plans to freely distribute its AI technology.

Meta's President expresses doubts about AI intelligence, specifically mentioning OpenAI and Google's models. The company shows commitment by open-sourcing their own model and partnering with Microsoft.

OpenAI Withholding GPT-4 Image Features Over Concerns of Privacy Issues

OpenAI limits GPT-4 model's image recognition over privacy concerns, reflecting their commitment to safety and responsible AI use.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img